These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18954260)

  • 21. Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
    Meshkani R; Sadeghi A; Taheripak G; Zarghooni M; Gerayesh-Nejad S; Bakhtiyari S
    Cell Biochem Funct; 2014 Dec; 32(8):683-91. PubMed ID: 25431031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
    Kim MJ; Leclercq P; Lanoy E; Cervera P; Antuna-Puente B; Maachi M; Dorofeev E; Slama L; Valantin MA; Costagliola D; Lombes A; Bastard JP; Capeau J
    Antivir Ther; 2007; 12(8):1273-83. PubMed ID: 18240867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosiglitazone increases the expression of peroxisome proliferator-activated receptor-gamma target genes in adipose tissue, liver, and skeletal muscle in the sheep fetus in late gestation.
    Muhlhausler BS; Morrison JL; McMillen IC
    Endocrinology; 2009 Sep; 150(9):4287-94. PubMed ID: 19520784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial.
    Hadigan C; Yawetz S; Thomas A; Havers F; Sax PE; Grinspoon S
    Ann Intern Med; 2004 May; 140(10):786-94. PubMed ID: 15148065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation.
    Finn AV; John M; Nakazawa G; Polavarapu R; Karmali V; Xu X; Cheng Q; Davis T; Raghunathan C; Acampado E; Ezell T; Lajoie S; Eppihimer M; Kolodgie FD; Virmani R; Gold HK
    Circ Res; 2009 Nov; 105(10):1003-12. PubMed ID: 19797172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development of subcutaneous sarcomas in rodents exposed to peroxisome proliferators agonists: hypothetical mechanisms of action and de-risking attitude.
    Pruimboom-Brees IM; Francone O; Pettersen JC; Kerlin RL; Will Y; Amacher DE; Boucher GG; Morton D
    Toxicol Pathol; 2012 Jul; 40(5):810-8. PubMed ID: 22504321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy.
    Guallar JP; Gallego-Escuredo JM; Domingo JC; Alegre M; Fontdevila J; Martínez E; Hammond EL; Domingo P; Giralt M; Villarroya F
    AIDS; 2008 Mar; 22(5):575-84. PubMed ID: 18316998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.
    He H; Tao H; Xiong H; Duan SZ; McGowan FX; Mortensen RM; Balschi JA
    Toxicol Sci; 2014 Apr; 138(2):468-81. PubMed ID: 24449420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.
    Carr A; Workman C; Carey D; Rogers G; Martin A; Baker D; Wand H; Law M; Samaras K; Emery S; Cooper DA;
    Lancet; 2004 Feb; 363(9407):429-38. PubMed ID: 14962523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of adipose tissues in the early hypolipidemic action of PPARgamma agonism in the rat.
    Laplante M; Festuccia WT; Soucy G; Gélinas Y; Lalonde J; Deshaies Y
    Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1408-17. PubMed ID: 17170230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo.
    Bogacka I; Xie H; Bray GA; Smith SR
    Diabetes; 2005 May; 54(5):1392-9. PubMed ID: 15855325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial Cell-Targeted Deletion of PPAR
    Akiyama TE; Skelhorne-Gross GE; Lightbody ED; Rubino RE; Shi JY; McNamara LA; Sharma N; Zycband EI; Gonzalez FJ; Liu H; Woods JW; Chang CH; Berger JP; Nicol CJB
    J Pharmacol Exp Ther; 2019 Mar; 368(3):514-523. PubMed ID: 30606762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial.
    van Wijk JP; de Koning EJ; Cabezas MC; op't Roodt J; Joven J; Rabelink TJ; Hoepelman AI
    Ann Intern Med; 2005 Sep; 143(5):337-46. PubMed ID: 16144892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial damage in adipose tissue of untreated HIV-infected patients.
    Garrabou G; López S; Morén C; Martínez E; Fontdevila J; Cardellach F; Gatell JM; Miró O
    AIDS; 2011 Jan; 25(2):165-70. PubMed ID: 21150553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance.
    Bastard JP; Caron M; Vidal H; Jan V; Auclair M; Vigouroux C; Luboinski J; Laville M; Maachi M; Girard PM; Rozenbaum W; Levan P; Capeau J
    Lancet; 2002 Mar; 359(9311):1026-31. PubMed ID: 11937183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPAR(gamma)/PGC-1(alpha) pathway in E-cadherin expression and motility of HepG2 cells.
    Lee HJ; Su Y; Yin PH; Lee HC; Chi CW
    Anticancer Res; 2009 Dec; 29(12):5057-63. PubMed ID: 20044617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway.
    Lin CY; Gurlo T; Haataja L; Hsueh WA; Butler PC
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6678-86. PubMed ID: 16204373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of PPAR gamma induces profound multilocularization of adipocytes in adult mouse white adipose tissues.
    Koh YJ; Park BH; Park JH; Han J; Lee IK; Park JW; Koh GY
    Exp Mol Med; 2009 Dec; 41(12):880-95. PubMed ID: 19745605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
    Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.